SBI Holdings Inc (SBHGF)
25.08
+0.72
(+2.96%)
USD |
OTCM |
May 10, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 6.914B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | 33.30% |
| Valuation | |
| PE Ratio | 12.38 |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 0.8976 |
| Price to Book Value | 0.8641 |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | 0.8592 |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 3.461 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 60.85% |
Profile
| SBI Holdings Inc is a financial conglomerate that offers a variety of services in securities, banking, and insurance. Operations are divided into financial services, asset management, and biotechnology-related business. Many of the traditional financial offerings fall under the financial services arm and include housing loans and foreign exchange margin trading in addition to the primary banking and insurance businesses. Under the asset management business, the group invests in Japanese and international venture companies that operate in IT, biotechnology, environment/energy, and finance. Aside from financial services, cosmetics, health foods, and drugs are developed by subsidiaries in the biotech-related business. |
| URL | http://www.sbigroup.co.jp |
| Investor Relations URL | https://www.sbigroup.co.jp/english/investors/ |
| HQ State/Province | N/A |
| Sector | Financials |
| Industry | Capital Markets |
| Equity Style | Large Cap/Blend |
| Next Earnings Release | N/A |
| Last Earnings Release | N/A |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Mar. 28, 2024 |
Ratings
Profile
| SBI Holdings Inc is a financial conglomerate that offers a variety of services in securities, banking, and insurance. Operations are divided into financial services, asset management, and biotechnology-related business. Many of the traditional financial offerings fall under the financial services arm and include housing loans and foreign exchange margin trading in addition to the primary banking and insurance businesses. Under the asset management business, the group invests in Japanese and international venture companies that operate in IT, biotechnology, environment/energy, and finance. Aside from financial services, cosmetics, health foods, and drugs are developed by subsidiaries in the biotech-related business. |
| URL | http://www.sbigroup.co.jp |
| Investor Relations URL | https://www.sbigroup.co.jp/english/investors/ |
| HQ State/Province | N/A |
| Sector | Financials |
| Industry | Capital Markets |
| Equity Style | Large Cap/Blend |
| Next Earnings Release | N/A |
| Last Earnings Release | N/A |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Mar. 28, 2024 |